Skip To Main Content
Okkeun Jung on Muck Rack

Okkeun Jung

As seen in: PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Okkeun

Contact Okkeun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity

|
By Okkeun Jung, Hunter College, Angelene Soto, Andrew L. Wolfe
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Jung O, Soto A, Wolfe AL, Mahajan SS (2025) Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity. PLoS One 20(8): e0329946. https://doi.org/10.1371/journal.pone.0329946 Editor: Jin-Ming Zhou, Zhejiang Normal University, CHINA Received: March 28, 2025; Accepted: July 23, 2025; Published: August 8, 2025 Copyright: © 2025 Jung et al.
Open in Who Shared Issue with article?
See all 1 articles